MSIP serves as the technology transfer office for the New York City-based Icahn School of Medicine of Mount Sinai and Mount Sinai Health System. MSIP aims to facilitate the management, licensing and commercialization of Mount Sinai researchers’ discoveries as well as encourage innovation across the system.
Here are four points:
1. Dr. Lium most recently served as senior vice president of Mount Sinai Innovation Partners.
2. Prior to joining Mount Sinai, he worked at UC San Francisco, serving in numerous roles such as assistant vice chancellor of innovation, technology and alliances.
3. He also founded and serves as president of LabVelocity, a company focused on accelerating research and development in the life sciences.
4. In his newly expanded role, Dr. Lium will work to create innovation-focused economic development initiatives, oversee the creation and growth of the i3 Asset Accelerator as well as advise Mount Sinai Ventures, the health system’s investment arm.
More articles on executive moves:
8 latest hospital, health system CFO moves
UW Health taps Elizabeth Bolt as COO: 4 things to know
Randolph Health CEO to depart in October
